Oligonucleotide and Peptide Based Therapeutics Congress
18 Nov 2013 - 19 Nov 2013 - San Diego, USA
The Oligonucleotide and Peptide Therapeutic market is growing rapidly. The increase of drug development programs in the sector as well as advancements in delivery solutions, away from injectables, has meant manufacturing production is increasing tremendously too.
Attracting experts working in all areas of Oligonucleotide and Peptide research and manufacture the conference will examine the latest discovery, pre-clinical and clinical based research, alongside cutting edge manufacturing and delivery solutions therefore helping with the continued advancement in development, reduction in cost, and commercialization of these type of drugs
The conference will provide an interactive networking forum by supplying a vibrant exhibition room full of manufacturing and technology providers showcasing their solutions, expert led case study presentations and interactive Q&A panel discussions examining topics through the four separate tracks outlined below.
Day One Stream One - Oligonucleotide Therapeutics R&D
Day One Stream Two - Peptide Therapeutics R&D
Day Two Stream One - Advances in Process Development & Manufacturing for Oligonucleotide and Peptides
Day Two Stream Two - Oligonucleotide & Peptide Delivery Strategies
The event offers a networking forum with a vibrant exhibition of manufacturing & technology providers showcasing their solutions, expert led case study presentations & interactive Q&A panel discussions examining key topics.